Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green in Nerve-Sparing Prostatectomy
NCT05960149Phase 4Not yet recruiting
- Sponsor
- Ankara University
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of indocyanine green in prostate cancer (PCa) (2 arms), sponsored by Ankara University. Primary endpoints: Evaluation of erectile function at 12 months and Evaluation of surgical margin positivity at 12 months. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05960149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05960149.